Clinical trials
Six studies, fourteen sites, all in the United States. Everything we know about our medicines and devices, we learned from people who volunteered.
Find a study
| Study | Condition | Candidate | Phase | Status | Locations | |
|---|---|---|---|---|---|---|
| KEYSTONE-1 NCT-BX0101-01 | Advanced solid tumours with KRAS G12D | BX-101 | Phase 1 | Recruiting | Miami FL, Tampa FL, Houston TX, Atlanta GA | Contact study team |
| SUMMIT-1 NCT-BX0204-01 | Fibrostenotic Crohn's disease | BX-204 | Phase 1 | Recruiting | West Palm Beach FL, Orlando FL, Chicago IL | Contact study team |
| ASCEND-1 NCT-BX0412-01 | Elevated lipoprotein(a) | BX-412 | Phase 1 | Recruiting | West Palm Beach FL, Nashville TN | Contact study team |
| HORIZON-0 Pending | Amyotrophic lateral sclerosis | BX-308 | IND-enabling | Not yet recruiting | US sites to be announced | Contact study team |
| LUMEN-1 NCT-BXLUM-01 | Perfusion assessment in colorectal anastomosis | Lumavue | Device feasibility | Completed | West Palm Beach FL, Boca Raton FL | Contact study team |
| LUMEN-2 NCT-BXLUM-02 | Perfusion-guided decision making, post-market | Lumavue | Post-market study | Recruiting | 6 US sites | Contact study team |
Registry identifiers shown are illustrative. Status is updated weekly; eligibility is always confirmed by the study doctor.
What taking part involves
A clinical trial is a carefully designed research study that tests whether an investigational medicine or device is safe and whether it works. Taking part is voluntary, and you can leave at any time without affecting your usual care.
- Screening — tests to confirm the study is appropriate for you
- Informed consent — a plain-language discussion before anything begins
- Treatment period — study visits, which in some designs include placebo
- Follow-up — safety checks after treatment ends
- Results — a lay summary sent to every participant
Phase 1 studies are the first time a medicine is given to people. Their main purpose is safety and dosing, not proving benefit — your study team will explain what that means for you.
Questions worth asking the study team
Why is this study being done?
The team should be able to state the specific question the study answers and what is already known.
Could I receive a placebo?
Some designs compare against placebo or standard of care. The consent form states your chance of each.
What are the possible risks?
Known effects from earlier studies, plus the risks of study procedures such as biopsies, scans or lumbar puncture.
Will it cost me anything?
Study medicine and study-related procedures are provided at no cost, and reasonable travel expenses are reimbursed.
What happens when the study ends?
Where a participant is benefiting, we provide continued access until the product is available another way.
Diversity in our trials
A medicine tested in one population cannot be assumed to behave the same way in another. South Florida is one of the most demographically varied clinical research environments in the country, and we set enrolment targets that reflect the real-world prevalence of each condition rather than whoever is easiest to recruit.
Interested in taking part?
Talk to your own doctor first, then contact a study team to check whether you are eligible.